栅栏技术中自体骨与50%脱蛋白牛骨基质/50%自体骨移植的临床双盲随机对照试验
本短期双盲平行随机对照试验比较了在引导骨再生栅栏技术中,使用100%自体骨(AB)或50%脱蛋白牛骨基质(DBBM)/50%自体骨(BOAB)进行骨增量移植,用于两阶段种植。并发症、椅旁时间、术后疼痛和功能受限无差异。
核心结论
- 除手术疼痛VAS和骨高度差异外,AB与BOAB在栅栏技术骨增量中无显著差异。
研究设计与样本
- 短期双盲、平行、随机对照临床试验,纳入广泛三维骨缺损的部分无牙颌患者,AB组15例,BOAB组15例。
主要发现
- 并发症、椅旁时间、术后疼痛和功能受限在AB与BOAB组间无差异。
临床怎么用
- 栅栏技术中AB与BOAB均可用于骨增量,BOAB可能提供更多骨高度增量,但手术疼痛略高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this short-term double-blind, parallel, randomized clinical trial was to compare bone augmentation grafting with 100% autogenous bone (AB) or 50% deproteinized bovine bone matrix (DBBM)/ 50% autogenous bone (BOAB) using a guided bone regeneration procedure, the fence technique, in a two-stage implant placement. MATERIAL AND METHODS: Partially edentulous patients with extensive three-dimensional osseous defects were included in this study. The main outcome measure was the differences in bone volume from pre-surgery (T1) to 6 months post-surgery (T2). Bone height, chair-time, pain, functional limitation, and complications were also assessed. RESULTS: Fifteen patients were allocated to the AB group and 15 patients to the BOAB group. The difference in bone volume from T1 to T2 was 648 mm3 for the AB group and 869mm3 for the BOAB group (difference between groups 221 mm3 , 95% CI from -363 to 804, p = .442). The surgery pain VAS was 1.6 for the AB group and 2.3 for the BOAB group (difference between groups 0.8, 95% CI from 0.0 to 1.5, p = .045 favoring the AB group). The height difference in bone from T1 to T2 was 2.2 mm for the AB group and 3.7 mm for the BOAB group (difference between groups 1.5mm, 95% CI from 0.1 to 2.9, p = .038 favoring the BOAB group). For complications, chair-time, post-surgery pain, and functional limitation, there were no differences between AB and BOAB. CONCLUSIONS: No significant differences, except for surgery pain VAS and difference in bone height, were observed in this trial comparing grafting with AB or BOAB.
引用
- Merli M, Nieri M, Mariotti G, et al. The fence technique: Autogenous bone graft versus 50% deproteinized bovine bone matrix / 50% autogenous bone graft-A clinical double-blind randomized controlled trial. Clin Oral Implants Res. 2020. PMID: 32979877. doi:10.1111/clr.13670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。